Development of (G3-C12)-mediated camptothecin polymeric prodrug targeting to Galectin-3 receptor against androgen-independent prostate cancer.

Yuan, Xia

Development of (G3-C12)-mediated camptothecin polymeric prodrug targeting to Galectin-3 receptor against androgen-independent prostate cancer. [electronic resource] - International journal of pharmaceutics Apr 2020 - 119123 p. digital

Publication Type: Journal Article

1873-3476

10.1016/j.ijpharm.2020.119123 doi


Animals
Blood Proteins--metabolism
Camptothecin--administration & dosage
Cell Line, Tumor
Cell Movement--drug effects
Cell Survival--drug effects
Dose-Response Relationship, Drug
Drug Delivery Systems--methods
Drug Development--methods
Galectins--metabolism
Humans
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Polymers--administration & dosage
Prodrugs--administration & dosage
Prostatic Neoplasms, Castration-Resistant--drug therapy
Xenograft Model Antitumor Assays--methods